Form 4 for JAGX Jaguar Health, Inc.
Accepted 2023-01-03 00:00:00 ET · period of report 2022-12-31 · accession 0001104659-23-000396 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-03 | 2022-12-31 | JAGX | Wolin Jonathan S. | CCO, GC, Chief of Staff | P - Purchase | $0.03 | +317 | 6,983 | +5% | +$9.51 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-31 | P | A | 317 | $0.03 | 6,983 | D | — | — |